Breakthrough pain in community-dwelling patients with cancer pain and noncancer pain, Part 2: Impact on function, mood, and quality of life

Journal of Opioid Management

Volumn 6, Issue 2, 2010, Pages 109-116

  Portenoy, Russell K ^a   Bruns, Daniel ^b   Shoemaker, Bonnie ^c   Shoemaker, Steven A ^c  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b Health Psychology Associates   (United States)

^c Sagemed Inc   (United States)

Author keywords

Breakthrough pain; Chronic pain; Functional impairment; Psychological distress

Indexed keywords

OPIATE;

AMBULATORY CARE; ARTICLE; ATTITUDE TO ILLNESS; BREAKTHROUGH PAIN; BRIEF PAIN INVENTORY; CANCER PAIN; CHRONIC PAIN; COMMUNITY LIVING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MOOD; OBSERVATIONAL STUDY; PAIN; PATIENT ATTITUDE; PHYSICIAN; PRIMARY MEDICAL CARE; PUBLIC HEALTH SERVICE; QUALITY OF LIFE; STRUCTURED INTERVIEW; TREATMENT DURATION; UNITED STATES;

ACTIVITIES OF DAILY LIVING; ADULT; AFFECT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; OUTPATIENTS; PAIN; PAIN MEASUREMENT; PAIN, INTRACTABLE; QUALITY OF LIFE; QUESTIONNAIRES; YOUNG ADULT;

EID: 77952353741     PISSN: 15517489     EISSN: None     Source Type: Journal    
DOI: 10.5055/jom.2010.0010     Document Type: Article

References (21)

1. Portenoy RK, Hagen NA: Breakthrough pain: Definition, prevalence and characteristics. Pain. 1990; 41(3): 273-281.
2. Svendsen KB, Andersen S, Arnason S, et al.: Breakthrough pain in malignant and non-malignant diseases: A review of prevalence, characteristics and mechanisms. Eur J Pain. 2005; 9(2): 195-206. (Pubitemid 40311842)
3. Zeppetella G, O'Doherty CA, Collins S: Prevalence and characteristics of breakthrough pain in cancer patients admitted to a hospice. J Pain Symptom Manage. 2000; 20: 87-92.
4. Portenoy RK, Payne D, Jacobsen P: Breakthrough pain: characteristics and impact in patients with cancer pain. Pain. 1999; 81: 129-134. (Pubitemid 29199908)
5. Højsted J, Nielsen PR, Eriksen J, et al.: Breakthrough pain in opioid-treated chronic non-malignant pain patients referred to a multidisciplinary pain centre: A preliminary study. Acta Anaesthesiol Scand. 2006; 50: 1290-1296. (Pubitemid 44624312)
6. Bruera E, Schoeller T, Wenk R, et al.: A prospective multicenter assessment of the Edmonton staging system for cancer pain. J Pain Symptom Manage. 1995; 10(5): 348-355.
7. Mercadante S, Maddaloni S, Roccella S, et al.: Predictive factors in advanced cancer pain treated only by analgesics. Pain. 1992; 50: 151-155.
8. Fortner BV, Okon TA, Portenoy RK: A survey of pain-related hospitalizations, emergency department visits, and physician office visits by cancer patients with and without breakthrough pain. Pain. 2002; 3: 38-44.
9. Portenoy RK, Bennett DS, Rauck R, et al.: Prevalence and characteristics of breakthrough pain in opioid-treated patients with chronic noncancer pain. J Pain. 2006; 7: 583-591. (Pubitemid 44137488)
10. Taylor DR, Webster L, Chun SY, et al.: Impact of breakthrough pain on quality of life in patients with chronic, non-cancer pain: Patient perceptions and effect of treatment with oral transmucosal fentanyl citrate (OTFC®, ACTIQ®). Pain Med. 2007; 6: 281-288. (Pubitemid 46443468)
11. Zeppetella G, O'Doherty CA, Collins S: Prevalence and characteristics of breakthrough pain in patients with non-malignant terminal disease admitted to a hospice. Palliat Med. 2001; 15(3): 243-246. (Pubitemid 32479462)
12. Cleeland CS, Ryan KM: Pain assessment: Global use of the Brief Pain Inventory. Ann Acad Med Singapore. 1994; 23: 129-138.
13. Keller S, Bann CM, Dodd SL, et al.: Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain. Clin J Pain. 2004; 20: 309-318. (Pubitemid 39108843)
14. Disorbio JM, Bruns D: Brief Battery for Health Improvement 2 Manual. Minneapolis, MN: Pearson, 2002.
15. Cohen J: Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ: Lawrence Erlbaum Associates, 1988.
16. Caraceni A, Martini C, Zecca E, et al.: Breakthrough pain characteristics and syndromes in patients with cancer pain. An international survey. Palliat Med. 2004; 18(3): 177-183.
17. Bhamb B, Brown D, Hariharan J, et al.: Survey of select practice behaviors by primary care physicians on the use of opioids for chronic pain. Curr Med Res Opin. 2006; 22: 1859-1865. (Pubitemid 44449242)
18. Cleeland CS, Janjan NA, Scott CB, et al.: Cancer pain management by radiotherapists: A survey of radiation therapy oncology group physicians. Int J Radiat Oncol Biol Phys. 2000; 47(1): 203-208.
19. Potter M, Schafer S, Gonzalez-Mendez E, et al.: Opioids for chronic nonmalignant pain: Attitudes and practices of primary care physicians in the UCSF/Stanford Collaborative Research Network. J Fam Pract. 2001; 50: 145-151. (Pubitemid 32147977)
20. Morley-Forster PK, Clark AJ, Speechley M, et al.: Attitudes toward opioid use for chronic pain: A Canadian physician survey. Pain Res Manage. 2003; 8(4): 189-194. (Pubitemid 43020581)
21. Devulder J, Jacobs A, Richarz U, et al.: Impact of opioid rescue medication for breakthrough pain on the efficacy and tolerability of long-acting opioids in patients with chronic non-malignant pain. Br J Anaesth. 2009; 103: 576-585.